Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/24738
Title: | Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2 |
Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
Keywords: | Adenocarcinoma/drug therapy/mortality/secondary,Aged,Aged, 80 and over,Antineoplastic Combined Chemotherapy Protocols/*therapeutic use,Bone Neoplasms/drug therapy/mortality/secondary,Brain Neoplasms/drug therapy/mortality/secondary,Carcinoma, Large Cell/diagnosis/genetics,Carcinoma, Non-Small-Cell Lung/*drug therapy/*mortality/secondary,Carcinoma, Squamous Cell/drug therapy/mortality/secondary,Disease Progression,Female,Follow-Up Studies,Humans,Liver Neoplasms/drug therapy/mortality/secondary,Lung Neoplasms/drug therapy/mortality/pathology,Lymphatic Metastasis,Male,Middle Aged,Neoplasm Recurrence, Local/*drug therapy/mortality/pathology,Neoplasm Staging,Paclitaxel/administration & dosage,Small Cell Lung Carcinoma/drug therapy/mortality/secondary,Survival Rate,Treatment Outcome,Vinblastine/administration & dosage/analogs & derivatives |
URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/24738 |
ISSN: | 1791-7530 |
Link: | http://www.ncbi.nlm.nih.gov/pubmed/22213304 |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License